The trials for a COVID-19 inactivated vaccine in the UAE have reached a key milestone.
Five thousand volunteers have been vaccinated since the testing programme began on July 16.
More than 80 different nationalities are currently participating in the third phase of the clinical trial that is open to all UAE residents as part of the #4Humanity programme.
Participants can register online, while there's also a dedicated centre each in Abu Dhabi and Sharjah to receive volunteers.
Up to 15,000 volunteers are required in order to conclude the scientific research phase.
G42 Healthcare is managing the overall clinical trial process under the supervision of the Department of Health Abu Dhabi (DoH) and in coordination with Abu Dhabi Health Services Company, SEHA.
The inactivated vaccine used in the trials has been developed by China's Sinopharm CNBG, and has shown promising results during the earlier Phase I and Phase II trials.
The #4Humanity COVID-19 inactivated vaccine trials today reached a significant milestone with the 5,000th volunteer vaccinated, testimony to the national spirit of volunteerism and strength of the healthcare system that has enabled the speed of this achievement. pic.twitter.com/qhY01uzPQy
— مكتب أبوظبي الإعلامي (@ADMediaOffice) August 6, 2020


UAE strongly condemns attacks by Houthi Group on Saudi civilian facilities
UAE allocates $8 million to support Chad amid El Nino food crisis
UAE, Syrian Presidents discuss stronger economic and development ties
Sheikha Latifa honours Arab Media Award winners
H.H. Sheikh Mohammed reaffirms 'relations with Syria' during meeting with Al-Sharaa
Abu Dhabi streamlines holiday home regulatory process
Ahmad Al-Sharaa expresses confidence in Syria's revival at Arab Media Summit
Sheikh Mansour, President of Angola discuss cooperation in phone call
